Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| U.S. Food And Drug Administration Approves Pfizer's INLYTA(R) (axitinib) For ... - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release) NEW YORK, Jan 27, 2012 (BUSINESS WIRE) -- Pfizer Inc. announced today that the US Food and Drug Administration (FDA) has approved INLYTA(R) (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC) after |
